Health · World
WHO Advises Against GLP-1 Drugs for Child Obesity, Favors Lifestyle Changes
The World Health Organization (WHO) has recommended lifestyle changes over GLP-1 drugs for combating child obesity. The organization's guidance suggests focusing on diet and exercise rather than pharmaceutical interventions for children. This stance comes amid a boom in compounding pharmacies offering weight-loss drugs, raising questions about their trustworthiness. While GLP-1 drugs are being explored for potential benefits in areas like compulsive shopping and gambling, the WHO's current advisory prioritizes broader health strategies for young people.
How outlets across the spectrum covered it
L 0 C 4 R 0
- Centre (4): CBS News, Forbes, Reuters, TIME